AYI · Acuity Inc. (De) · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-02 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. |
Common Stock
|
1,000 |
| 2026-11-02 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. |
Common Stock
|
3,000 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.51 to $323.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
920 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.55 to $315.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,040 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.79 to $317.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
560 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.69 to $316.39, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
817 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.72 to $325.19, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
282 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $320.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
772 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.68 to $324.51 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
238 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.28 to $322.26, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
388 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.90 to $318.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,640 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.55 to $314.45, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
760 |
| 2026-10-30 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.90 to $319.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
800 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.94 to $327.76, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
480 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $321.02, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
400 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.45 to $322.32 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
720 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.14 to $316.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
240 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.91 to $324.69, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,320 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.51 to $318.41, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
120 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.92 to $326.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,155 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.59 to $323.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
240 |
| 2026-10-29 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.92 to $325.86, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
3,512 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.28 to $318.09, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
280 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.55 to $317.52, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
6,544 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.55 to $316.54, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
5,286 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.59 to $318.59, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
7,295 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.61 to $319.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,948 |
| 2026-10-28 | ASHE NEIL |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.32 to $315.31, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
707 |
| 2026-10-27 | GOLDMAN BARRY R |
SVP & General Counsel |
Sell↓
|
Common Stock
|
3,800 |
| 2026-10-24 | ASHE NEIL |
Director, President & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
26,749 |
| 2026-10-24 | GOLDMAN BARRY R |
SVP & General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
The shares were issued upon the achievement and subsequent vesting of performance stock units (PSUs). These PSUs were granted on October 24, 2023, with a three-year performance period that began September 1, 2023 and ended August 31, 2026. On October 22, 2026, the Compensation and Management Development Committee certified the achievement of the performance measures and authorized the issuance of common stock underlying the PSUs on their vesting date, October 24, 2026. |
Common Stock
|
7,394 |
| 2026-10-24 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares were issued upon the achievement and subsequent vesting of performance stock units (PSUs). These PSUs were granted on October 24, 2023, with a three-year performance period that began September 1, 2023 and ended August 31, 2026. On October 22, 2026, the Compensation and Management Development Committee certified the achievement of the performance measures and authorized the issuance of common stock underlying the PSUs on their vesting date, October 24, 2026. |
Common Stock
|
12,200 |
| 2026-10-24 | GOLDMAN BARRY R |
SVP & General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
3,476 |
| 2026-10-24 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
6,066 |
| 2026-10-24 | ASHE NEIL |
Director, President & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares were issued upon the achievement and subsequent vesting of performance stock units (PSUs). These PSUs were granted on October 24, 2023, with a three-year performance period that began September 1, 2023 and ended August 31, 2026. On October 22, 2026, the Compensation and Management Development Committee certified the achievement of the performance measures and authorized the issuance of common stock underlying the PSUs on their vesting date, October 24, 2026. |
Common Stock
|
55,452 |
| 2026-10-23 | ASHE NEIL |
Director, President & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
661 |
| 2026-10-23 | Dadyar Sara |
Managing Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
103 |
| 2026-10-23 | GOLDMAN BARRY R |
SVP & General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
128 |
| 2026-10-23 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transactions report the withholding of stock to cover tax liability associated with the vesting of restricted stock units or PSUs held by the reporting person. |
Common Stock
|
225 |
| 2026-10-22 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock unit awards were issued pursuant to the Amended and Restated Acuity Inc. 2012 Omnibus Stock Incentive Compensation Plan. The common shares underlying the award vest in three equal annual installments beginning on October 22, 2027. |
Common Stock
|
2,648 |
| 2026-10-22 | ASHE NEIL |
Director, President & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock unit awards were issued pursuant to the Amended and Restated Acuity Inc. 2012 Omnibus Stock Incentive Compensation Plan. The common shares underlying the award vest in three equal annual installments beginning on October 22, 2027. |
Common Stock
|
8,078 |
| 2026-10-22 | GOLDMAN BARRY R |
SVP & General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock unit awards were issued pursuant to the Amended and Restated Acuity Inc. 2012 Omnibus Stock Incentive Compensation Plan. The common shares underlying the award vest in three equal annual installments beginning on October 22, 2027. |
Common Stock
|
1,734 |
| 2026-10-22 | Dadyar Sara |
Managing Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock unit awards were issued pursuant to the Amended and Restated Acuity Inc. 2012 Omnibus Stock Incentive Compensation Plan. The common shares underlying the award vest in three equal annual installments beginning on October 22, 2027. |
Common Stock
|
1,388 |
| 2026-10-16 | O'Shaughnessy Laura |
Director |
Buy↑
|
Common Stock
|
73 |
| 2026-09-24 | Tzitzon Nicholas |
Director |
Award↑
Filing footnotes — Deferred Restricted Stock Units (Direct)
1-for-1 Deferred Restricted Stock Units (DSUs) issued pursuant to the Issuer's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan. The DSUs resulted from the Reporting Person's election to receive a portion of annual director fees in the form of a DSU. The DSUs will vest in full on the first anniversary of the grant date, or, if earlier, the date of the next subsequent annual meeting of the Issuer's stockholders following the grant date. Once vested, DSUs will be payable upon retirement in either lump sum or five annual installments. |
Deferred Restricted Stock Units
|
296 |
| 2026-09-01 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29,2025. |
Common Stock
|
2,000 |
| 2026-07-02 | GOLDMAN BARRY R |
SVP & General Counsel |
Sell↓
|
Common Stock
|
1,200 |
| 2026-06-01 | HOLCOM KAREN J |
SVP & Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2025. |
Common Stock
|
2,076 |
| 2026-04-30 | Leibman Maya |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The shares reported are held by the CDP Trust U/A, for which the reporting person is a co-trustee. |
Common Stock
(I)
|
200 |
| 2026-04-08 | O'Shaughnessy Laura |
Director |
Buy↑
|
Common Stock
|
1,000 |